UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
PASW, Inc
(Name of Issuer)
Common Stock, $0.00001 par value
(Title of Class of Securities)
693153108
(CUSIP Number)
Kendall Larsen
5615 Scotts Valley Drive, Suite 110,
Scotts Valley, California 95066
(831) 438-8200
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
July 5, 2007
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of section 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. □
CUSIP No. 693153108 | |||
1. | Names of Reporting Persons. Robert M. Levande | ||
2. | Check the Appropriate Box if a Member of a Group (a) □ (b) □ | ||
3. | SEC Use Only | ||
4. | Source of Funds OO/PF | ||
5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) □ | ||
6. | Citizenship or Place of Organization United States | ||
Number of Shares Beneficially Owned By Each Reporting Person With | 7. | Sole Voting Power 6,252,303 (1) | |
8. | Shared Voting Power 0 | ||
9. | Sole Dispositive Power 6,252,303 (1) | ||
10. | Shared Dispositive Power 0 | ||
11. | Aggregate Amount Beneficially Owned by Each Reporting Person 6,252,303 (1) | ||
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares □ | ||
13. | Percent of Class Represented by Amount in Row (11) 6.680% based upon total number of shares reported to be outstanding. | ||
14. | Type of Reporting Person IN | ||
(1) Includes 622,739 shares held by the Arthur Brown Trust FBO Carolyn Brown Levande. | |||
2
EXPLANATORY NOTE
Beginning on the date this Schedule 13D (the “Schedule 13D”) is filed with the Securities and Exchange Commission (the “Commission”) on behalf of Robert Levande (the “Reporting Person”), and continuing thereafter until the date on which any further amendment or supplement, as applicable, with respect to this Schedule 13D shall be filed with the Commission on behalf of the Reporting Person, all references to the Schedule 13D shall hereafter be deemed to refer to this Schedule 13D, as such may be hereafter amended or supplemented, as applicable. Disclosure in any Item of this Schedule 13D of any information shall be deemed to be adequate disclosure of such information with respect to all Items of this Schedule 13D calling for disclosure of such information, whether or not such disclosure is specifically associated with or purports to respond to one or more or all of such Items to the extent that it is reason ably apparent that such disclosure is applicable.
Item 1. Security and Issuer
This Schedule 13D relates to the common stock, par value $0.00001 per share (the “Common Stock”), of PASW, Inc. (the “Issuer”). The address of the principal executive offices of the Issuer is c/o PASW, Inc., 5615 Scotts Valley Drive, Suite 110, Scotts Valley, CA 95066.
Item 2. Identity and Background
(a)
The name of the Reporting Person is Robert Levande.
(b)
The business address of the Reporting Person is c/o Kendall Larsen, President and Chief Executive Officer, PASW, Inc., 5615 Scotts Valley Drive, Suite 110, Scotts Valley, CA 95066.
(c)
The present principal occupation of the Reporting Person is Managing Director of
(d)
MDB Capital Group LLC.
(e)
The Reporting Person has not, during the last five years, been convicted in a criminal
(f)
proceeding (excluding traffic violations or similar misdemeanors).
(g)
The Reporting Person has not, during the last five years, been a party to a civil
(h)
proceeding of a judicial or administrative body of competent jurisdiction.
(i)
The Reporting Person is a citizen of United States.
Item 3. Source and Amount of Funds or Other Consideration
Reference is made to the disclosure provided in Item 4, Item 5 and Item 7 of this Schedule 13D; and such disclosure provided therein is, to the extent applicable to this Item, incorporated by reference into this Item.
3
Item 4. Purpose of Transaction
On July 12, 2007, the Issuer entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Issuer, VirnetX Acquisition, Inc., a wholly owned subsidiary of the Issuer (the “Merger Sub”), and VirnetX, Inc. (the “Acquired Company”), providing for the merger of the Merger Sub with and into the Acquired Company, and pursuant to which the Acquired Company became the surviving corporation and a wholly-owned subsidiary of the Issuer (the “Merger”). Pursuant to the Merger Agreement, among other things, all the securities of the Acquired Company (the “Acquired Company Securities”) were converted into securities of the Issuer.
Item 5. Interest in Securities of the Issuer
(a)
The aggregate number of shares of the Common Stock beneficially owned by the Reporting Person is 6,252,303, which represents beneficial ownership of the Reporting Person of approximately 6.68% of the Common Stock.
(b)
The Reporting Person has the sole power to vote, or to direct the vote, and the sole power to dispose, or to direct the disposition of, all such 6,252,303 shares of Common Stock beneficially owned by the Reporting Person.
(c)
Not applicable.
(d)
Not applicable.
(e)
Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer
Reference is made to the disclosure provided in Item 4, Item 5 and Item 7 of this Schedule 13D, and such disclosure provided therein is, to the extent applicable, hereby incorporated by reference into this Item.
Item 7. Material to Be Filed as Exhibits
Number
Description
99.1
Power of Attorney on behalf of Robert Levande dated as of July 12, 2007
4
Signatures
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: July 16, 2007
/s/Robert M. Levande
Kendall Larsen,
Attorney-in-Fact
for Robert M. Levande
5
POWER OF ATTORNEY
The undersigned hereby constitutes and appoints Kendall Larsen and/or Sameer Mathur, his or her, true and lawful attorney-in-fact to:
(1)
execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director, and/or person who holds more than 10% of the stock of PASW, Inc. (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules thereunder;
(2)
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment(s) thereto, and timely file any such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3)
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done pursuant to this power of attorney. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the attorneys-in-fact. This Power of Attorney may be filed with the SEC as a confirming statement of the authority granted herein.
The undersigned has caused this Power of Attorney to be executed as of this 12th day of July, 2007.
/s/ Robert Levande
Robert Levande